ClinConnect ClinConnect Logo
Search / Trial NCT01229475

Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation

Launched by DEUTSCHES HERZZENTRUM MUENCHEN · Oct 26, 2010

Trial Information

Current as of June 03, 2025

Unknown status

Keywords

Atrial Fibrillation Recurrence Repeat Procedure Linear Ablation Stepwise Approach

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with recurrence of symptomatic persistent atrial fibrillation after at least one ablation procedure,
  • with the last ablation procedure at least 3 months ago.
  • at least one unsuccessful attempt of antiarrhythmic drug
  • oral anticoagulation for at least 4 weeks prior to ablation
  • Exclusion Criteria:
  • LA thrombus

About Deutsches Herzzentrum Muenchen

Deutsches Herzzentrum München (German Heart Center Munich) is a leading institution in cardiovascular medicine, dedicated to advancing research, treatment, and education in heart health. Affiliated with the Technical University of Munich, the center specializes in innovative clinical trials aimed at improving diagnostic and therapeutic approaches for heart diseases. With a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to patient-centered care, Deutsches Herzzentrum München is at the forefront of developing novel interventions and enhancing clinical outcomes in cardiovascular health.

Locations

Munich, , Germany

Patients applied

0 patients applied

Trial Officials

Isabel Deisenhofer, MD

Study Chair

Deutsches Herzzentrum München

Sonia Ammar, MD

Principal Investigator

Deutsches Herzzentrum München

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials